Related references
Note: Only part of the references are listed.N-Methylpropargylamine-Conjugated Hydroxamic Acids as Dual Inhibitors of Monoamine Oxidase A and Histone Deacetylase for Glioma Treatment
Samir Mehndiratta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Deletion of monoamine oxidase A in a prostate cancer model enhances anti-tumor immunity through reduced immune suppression
Jessica A. Lapierre et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)
Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation
Yu-Ting Tsai et al.
JOURNAL OF BIOMEDICAL SCIENCE (2022)
RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences
Stephen K. Burley et al.
NUCLEIC ACIDS RESEARCH (2021)
Synthesis and in vitro study of nitro- and methoxy-2-phenylbenzofurans as human monoamine oxidase inhibitors
Giovanna L. Delogu et al.
BIOORGANIC CHEMISTRY (2021)
Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: A preliminary attempt to unravel the enigma of glioblastoma
Kunal Nepali et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Brain and other central nervous system tumor statistics, 2021
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
17β-estradiol induces temozolomide resistance through NRF2-mediated redox homeostasis in glioblastoma
Hong-Yi Lin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
HSP90 Inhibition Enhances Cancer Immunotherapy by Modulating the Surface Expression of Multiple Immune Checkpoint Proteins
Reza Beheshti Zavareh et al.
CELL CHEMICAL BIOLOGY (2021)
N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-gamma induced PD-L1 expression
Samir Mehndiratta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2020)
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes
Shikha Kumari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Hsp90 chaperones have an energetic hot-spot for binding inhibitors
Reyal S. Hoxie et al.
PROTEIN SCIENCE (2020)
Potential monoamine oxidase A inhibitor suppressing paclitaxel-resistant non-small cell lung cancer metastasis and growth
Xiaoguang Yang et al.
THORACIC CANCER (2020)
Novel Treatment Strategies for Glioblastoma
Stanley S. Stylli
CANCERS (2020)
Multi-Cell Type Glioblastoma Tumor Spheroids for Evaluating Sub-Population-Specific Drug Response
Hemamylammal Sivakumar et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
An insight on medicinal attributes of 1,2,4-triazoles
Ranjana Aggarwal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
PAMs inhibits monoamine oxidase a activity and reduces glioma tumor growth, a potential adjuvant treatment for glioma
Pei-Chuan Li et al.
BMC COMPLEMENTARY MEDICINE AND THERAPIES (2020)
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Xianjie Jiang et al.
MOLECULAR CANCER (2019)
Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate
Chun-Peng Liao et al.
ONCOGENE (2018)
Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy
Jean C. Shih
JOURNAL OF NEURAL TRANSMISSION (2018)
The IFN-gamma/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
Jiawen Qian et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase
Kwang-Yu Chang et al.
REDOX BIOLOGY (2017)
HER2-targeted recombinant protein immuno-caspase-6 effectively induces apoptosis in HER2-overexpressing GBM cells in vitro and in vivo
Leiming Zhang et al.
ONCOLOGY REPORTS (2016)
Linking HSP90 target occupancy to HSP70 induction and efficacy in mouse brain
Kenneth Thirstrup et al.
PHARMACOLOGICAL RESEARCH (2016)
Monoamine oxidase A (MAO A) inhibitors decrease glioma progression
Swati Kushal et al.
ONCOTARGET (2016)
Monoamine Oxidase A Inhibitor-Near-Infrared Dye Conjugate Reduces Prostate Tumor Growth
Jason Boyang Wu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis
Jason Boyang Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Synthesis and Evaluation of New Hsp90 Inhibitors Based on a 1,4,5-Trisubstituted 1,2,3-Triazole Scaffold
Maurizio Taddei et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models
Kaijun Di et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
An Impermeant Ganetespib Analog Inhibits Extracellular Hsp90-Mediated Cancer Cell Migration that Involves Lysyl Oxidase 2-like Protein
Jessica McCready et al.
CANCERS (2014)
Current Place of Monoamine Oxidase Inhibitors in the Treatment of Depression
Kenneth I. Shulman et al.
CNS DRUGS (2013)
Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non-Small Cell Lung Cancer
Takeshi Shimamura et al.
CLINICAL CANCER RESEARCH (2012)
Novel Therapies in Glioblastoma
James Perry et al.
NEUROLOGY RESEARCH INTERNATIONAL (2012)
Targeting the AKT Pathway in Glioblastoma
Kelli A. McDowell et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
Nabil Ahmed et al.
CLINICAL CANCER RESEARCH (2010)
Mechanistic Evaluation of the Novel HSP90 Inhibitor NVP-AUY922 in Adult and Pediatric Glioblastoma
Nathalie Gaspar et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Targeting the dynamic HSP90 complex in cancer
Jane Trepel et al.
NATURE REVIEWS CANCER (2010)
Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells
Claire Marie-Elisabeth Sauvageot et al.
NEURO-ONCOLOGY (2009)
17-AAG sensitized malignant glioma cells to death-receptor mediated apoptosis
Markus David Siegelin et al.
NEUROBIOLOGY OF DISEASE (2009)
Can The Lack of HSP90 Protein in Brain Normal Tissue and Cell Lines, Rationalise it as a Possible Therapeutic Target for Gliomas?
Amal Shervington et al.
CANCER INVESTIGATION (2008)
4,5-diarylisoxazole HSP90 chaperone inhibitors: Potential therapeutic agents for the treatment of cancer
Paul A. Brough et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Three-dimensional structure of human monoamine oxidase A (MAO A): Relation to the structures of rat MAO A and human MAO B
L De Colibus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
R1, a novel repressor of the human monoamine oxidase A
K Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening
TA Halgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice
EC Holland et al.
NATURE GENETICS (2000)
Share Paper
